The drug hub of Mumbai , India , has emerged as a crucial center for the creation of Tetrabenazine API (CAS No. 58-46-8). Several trusted companies are focused on the creation of this key active pharmaceutical ingredient. These businesses often provide Tetrabenazine to both the internal and foreign markets, adhering to stringent regulatory standard